Ferrous Fumarate, Folic Acid

FDA Drug Profile — Prenatrix, Vitrexate FE, Pretrate, Ribotin-E, Prenatryl

Ferrous Fumarate, Folic Acid is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand names including Prenatrix, Vitrexate FE, Pretrate. Available dosage form: tablet.

Drug details

Generic Name
Ferrous Fumarate, Folic Acid
Brand Names
Prenatrix, Vitrexate FE, Pretrate, Ribotin-E, Prenatryl, Zintrexyl-C, Folitin-Z, Prometa, Vitranol Fe, Matronex, Foliflex, Ventrixyl Fe, Vitrexyl plus Iron, Venexa FE
Sponsor
PureTek Corporation
NDC Codes
14
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
FERROUS FUMARATE, ZINC OXIDE, MOLYBDENUM, CHOLINE BITARTRATE, CHROMIUM NICOTINATE, SELENIUM, POTASSIUM IODIDE, MAGNESIUM OXIDE, MANGANESE SULFATE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, BIOTIN, PANTOTHENIC ACID, CUPROUS OXIDE, POTASSIUM CHLORIDE, BORON

Indications and Usage

INDICATIONS: Folitin-Z TM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for the treatment of the condition in which iron deficiency and vitamin C deficiency occurs together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence.

Warnings

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. Administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. Precaution Section Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folic acid to patients with undiagnosed anemia, since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered. For use on the order of a healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek Corporation at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Drug Interactions: Folitin-Z TM is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel). Adverse Reactions: Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Folitin-Z TM after meals may control occasional gastrointestinal disturbances. Folitin-Z TM is best absorbed when taken at bedtime. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usually recommended levels, has been associated with gastrointestinal intolerance in some patients.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.